Isofol Medical Balance Sheet Health
Financial Health criteria checks 6/6
Isofol Medical has a total shareholder equity of SEK121.4M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK140.6M and SEK19.2M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr138.15m |
| Equity | kr121.43m |
| Total liabilities | kr19.16m |
| Total assets | kr140.60m |
Recent financial health updates
Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation
Nov 09
Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?
May 12We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully
Jan 10
Recent updates
An Intrinsic Calculation For Isofol Medical AB (publ) (STO:ISOFOL) Suggests It's 45% Undervalued
May 18Here's Why We're Not At All Concerned With Isofol Medical's (STO:ISOFOL) Cash Burn Situation
Nov 09Is Isofol Medical (STO:ISOFOL) In A Good Position To Deliver On Growth Plans?
May 12Market Sentiment Around Loss-Making Isofol Medical AB (publ) (STO:ISOFOL)
Apr 08Isofol Medical (STO:ISOFOL) Has Gifted Shareholders With A Fantastic 127% Total Return On Their Investment
Mar 03We Think Isofol Medical (STO:ISOFOL) Needs To Drive Business Growth Carefully
Jan 10Financial Position Analysis
Short Term Liabilities: ISOFOL's short term assets (SEK140.6M) exceed its short term liabilities (SEK18.3M).
Long Term Liabilities: ISOFOL's short term assets (SEK140.6M) exceed its long term liabilities (SEK911.0K).
Debt to Equity History and Analysis
Debt Level: ISOFOL is debt free.
Reducing Debt: ISOFOL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ISOFOL has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ISOFOL has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 8.1% each year.